Conditionally replicating adenovirus expressing TIMP2 increases survival in a mouse model of disseminated ovarian cancer.
Ovarian cancer remains difficult to treat mainly due to presentation of the disease at an advanced stage. Conditionally-replicating adenoviruses (CRAds) are promising anti-cancer agents that selectively kill the tumor cells. The present study evaluated the efficacy of a novel CRAd (Ad5/3-CXCR4-TIMP2...
Main Authors: | Sherry W Yang, Diptiman Chanda, James J Cody, Angel A Rivera, Reinhard Waehler, Gene P Siegal, Joanne T Douglas, Selvarangan Ponnazhagan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3192051?pdf=render |
Similar Items
-
Novel Infectivity-Enhanced Oncolytic Adenovirus with a Capsid-Incorporated Dual-Imaging Moiety for Monitoring Virotherapy in Ovarian Cancer
by: Kristopher J. Kimball, et al.
Published: (2009-09-01) -
Recombinant AAV-CEA Tumor Vaccine in Combination with an Immune Adjuvant Breaks Tolerance and Provides Protective Immunity
by: Jonathan A. Hensel, et al.
Published: (2019-03-01) -
Targeting CA-125 Transcription by Development of a Conditionally Replicative Adenovirus for Ovarian Cancer Treatment
by: Er Yue, et al.
Published: (2021-08-01) -
Disseminated adenovirus infection in heart and kidney transplant
by: Jack Xu, et al.
Published: (2018-04-01) -
Disseminated Adenovirus Nephritis After Kidney Transplantation
by: Timothy Hatlen, et al.
Published: (2018-01-01)